The global market for Multiplex Sepsis Biomarker Panel was valued at US$ 152 million in the year 2024 and is projected to reach a revised size of US$ 254 million by 2031, growing at a CAGR of 7.8% during the forecast period.

Multiplex Sepsis Biomarker Panel Market

A Multiplex Sepsis Biomarker Panel is an in-vitro diagnostic solution designed to simultaneously quantify multiple biomarkers that reflect inflammation, immune dysregulation, tissue injury, and pathogen-related responses in patients with sepsis. Compared with single-analyte assays, multiplex panels measure key indicators such as PCT, CRP, IL-6, IL-8, TNF-α, D-dimer, metabolic markers, and host-response signals within one analysis, enabling multidimensional and mechanism-driven assessment. The technology supports earlier detection, accurate risk stratification, personalized treatment decisions, and more responsible antibiotic use. With the advancement of multiplex immunoassay and molecular platforms, multiplex sepsis panels are becoming a cornerstone of precision critical-care diagnostics.The average gross profit margin of this product is 43%.

The growth of multiplex sepsis biomarker panels is fueled by the acceleration of precision medicine, transformation of critical-care management, and hospitals’ increasing reliance on high-value diagnostic intelligence. As sepsis becomes a priority quality indicator globally, the need for earlier detection, rapid stratification, and more rational antimicrobial use is rising. Multiplex panels integrate multiple pathological signals into a single test, improving diagnostic efficiency and treatment specificity across ICUs, emergency departments, operating rooms, and high-risk wards. Advances in high-sensitivity multiplex immunoassays and microfluidic platforms further support technology adoption.

Adoption is moderated by cost considerations, platform compatibility, and the clinical learning curve associated with interpreting multi-analyte results. Budget constraints at some hospitals and limited clinician training may slow penetration. Additionally, multiplex panels require complex quality control, inter-batch consistency, and long-term stability validation, resulting in lengthy development and regulatory cycles. Increasing regulatory rigor also demands a careful balance between performance, reproducibility, and robust clinical evidence.

Downstream demand is shifting from single-marker testing toward integrated, mechanism-driven diagnostics. Hospitals seek treatment-guiding information at early clinical windows, accelerating the use of multiplex panels supporting early antimicrobial decisions. Critical-care centers and tertiary hospitals are incorporating multiplex testing into standardized workflows to improve diagnostic accuracy. The expansion of remote monitoring, smart ICUs, and point-of-care technologies is also driving demand for more compact, faster, and automated multiplex systems.

Upstream components include high-specificity antibodies and probes, microfluidic chips, magnetic beads, optical detection modules, and specialized biochemical consumables. These materials directly influence analytical sensitivity, interference control, and assay robustness. With advances in materials science and manufacturing technologies, upstream supply is evolving toward higher stability, lower background, and greater support for high-throughput multiplexing, enabling continuous product performance improvement.

This report aims to provide a comprehensive presentation of the global market for Multiplex Sepsis Biomarker Panel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplex Sepsis Biomarker Panel.

The Multiplex Sepsis Biomarker Panel market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiplex Sepsis Biomarker Panel market comprehensively. Regional market sizes, concerning products by Type, by Application, by Diagnostic Fields and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Multiplex Sepsis Biomarker Panel companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Multiplex Sepsis Biomarker Panel Market Report

Report Metric	Details
Report Name	Multiplex Sepsis Biomarker Panel Market
Accounted market size in year	US$ 152 million
Forecasted market size in 2031	US$ 254 million
CAGR	7.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Multiplex Immunoassay Microfluidics-Based Panels Multiplex Molecular Panels Other
Segment by Diagnostic Fields	Sepsis Diagnosis Sepsis Prognosis Other
Segment by Clinical Application Scenarios	ED Rapid Triage ICU Monitoring Antimicrobial Stewardship Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Atila Biosystems, EDX Medical, Seegene Inc, BIOMÉRIEUX, GCC Biotech INDIA, Labmix24, Assay Genie Ltd, T2 Biosystems, Immunexpress, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Diagnostic Fields etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplex Sepsis Biomarker Panel company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Multiplex Sepsis Biomarker Panel Market growing?

Ans: The Multiplex Sepsis Biomarker Panel Market witnessing a CAGR of 7.8% during the forecast period 2025-2031.

What is the Multiplex Sepsis Biomarker Panel Market size in 2031?

Ans: The Multiplex Sepsis Biomarker Panel Market size in 2031 will be US$ 254 million.

Who are the main players in the Multiplex Sepsis Biomarker Panel Market report?

Ans: The main players in the Multiplex Sepsis Biomarker Panel Market are Atila Biosystems, EDX Medical, Seegene Inc, BIOMÉRIEUX, GCC Biotech INDIA, Labmix24, Assay Genie Ltd, T2 Biosystems, Immunexpress, Merck

What are the Application segmentation covered in the Multiplex Sepsis Biomarker Panel Market report?

Ans: The Applications covered in the Multiplex Sepsis Biomarker Panel Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Multiplex Sepsis Biomarker Panel Market report?

Ans: The Types covered in the Multiplex Sepsis Biomarker Panel Market report are Multiplex Immunoassay, Microfluidics-Based Panels, Multiplex Molecular Panels, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Multiplex Immunoassay

1.2.3 Microfluidics-Based Panels

1.2.4 Multiplex Molecular Panels

1.2.5 Other

1.3 Market by Diagnostic Fields

1.3.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Diagnostic Fields: 2020 VS 2024 VS 2031

1.3.2 Sepsis Diagnosis

1.3.3 Sepsis Prognosis

1.3.4 Other

1.4 Market by Clinical Application Scenarios

1.4.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Clinical Application Scenarios: 2020 VS 2024 VS 2031

1.4.2 ED Rapid Triage

1.4.3 ICU Monitoring

1.4.4 Antimicrobial Stewardship

1.4.5 Other

1.5 Market by Application

1.5.1 Global Multiplex Sepsis Biomarker Panel Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Multiplex Sepsis Biomarker Panel Market Perspective (2020-2031)

2.2 Global Multiplex Sepsis Biomarker Panel Growth Trends by Region

2.2.1 Global Multiplex Sepsis Biomarker Panel Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Multiplex Sepsis Biomarker Panel Historic Market Size by Region (2020-2025)

2.2.3 Multiplex Sepsis Biomarker Panel Forecasted Market Size by Region (2026-2031)

2.3 Multiplex Sepsis Biomarker Panel Market Dynamics

2.3.1 Multiplex Sepsis Biomarker Panel Industry Trends

2.3.2 Multiplex Sepsis Biomarker Panel Market Drivers

2.3.3 Multiplex Sepsis Biomarker Panel Market Challenges

2.3.4 Multiplex Sepsis Biomarker Panel Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Multiplex Sepsis Biomarker Panel Players by Revenue

3.1.1 Global Top Multiplex Sepsis Biomarker Panel Players by Revenue (2020-2025)

3.1.2 Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Players (2020-2025)

3.2 Global Top Multiplex Sepsis Biomarker Panel Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Multiplex Sepsis Biomarker Panel Revenue

3.4 Global Multiplex Sepsis Biomarker Panel Market Concentration Ratio

3.4.1 Global Multiplex Sepsis Biomarker Panel Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Multiplex Sepsis Biomarker Panel Revenue in 2024

3.5 Global Key Players of Multiplex Sepsis Biomarker Panel Head office and Area Served

3.6 Global Key Players of Multiplex Sepsis Biomarker Panel, Product and Application

3.7 Global Key Players of Multiplex Sepsis Biomarker Panel, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Multiplex Sepsis Biomarker Panel Breakdown Data by Type

4.1 Global Multiplex Sepsis Biomarker Panel Historic Market Size by Type (2020-2025)

4.2 Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Type (2026-2031)

5 Multiplex Sepsis Biomarker Panel Breakdown Data by Application

5.1 Global Multiplex Sepsis Biomarker Panel Historic Market Size by Application (2020-2025)

5.2 Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Multiplex Sepsis Biomarker Panel Market Size (2020-2031)

6.2 North America Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)

6.4 North America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Multiplex Sepsis Biomarker Panel Market Size (2020-2031)

7.2 Europe Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)

7.4 Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size (2020-2031)

8.2 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025)

8.4 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Multiplex Sepsis Biomarker Panel Market Size (2020-2031)

9.2 Latin America Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)

9.4 Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size (2020-2031)

10.2 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)

10.4 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Atila Biosystems

11.1.1 Atila Biosystems Company Details

11.1.2 Atila Biosystems Business Overview

11.1.3 Atila Biosystems Multiplex Sepsis Biomarker Panel Introduction

11.1.4 Atila Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.1.5 Atila Biosystems Recent Development

11.2 EDX Medical

11.2.1 EDX Medical Company Details

11.2.2 EDX Medical Business Overview

11.2.3 EDX Medical Multiplex Sepsis Biomarker Panel Introduction

11.2.4 EDX Medical Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.2.5 EDX Medical Recent Development

11.3 Seegene Inc

11.3.1 Seegene Inc Company Details

11.3.2 Seegene Inc Business Overview

11.3.3 Seegene Inc Multiplex Sepsis Biomarker Panel Introduction

11.3.4 Seegene Inc Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.3.5 Seegene Inc Recent Development

11.4 BIOMÉRIEUX

11.4.1 BIOMÉRIEUX Company Details

11.4.2 BIOMÉRIEUX Business Overview

11.4.3 BIOMÉRIEUX Multiplex Sepsis Biomarker Panel Introduction

11.4.4 BIOMÉRIEUX Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.4.5 BIOMÉRIEUX Recent Development

11.5 GCC Biotech INDIA

11.5.1 GCC Biotech INDIA Company Details

11.5.2 GCC Biotech INDIA Business Overview

11.5.3 GCC Biotech INDIA Multiplex Sepsis Biomarker Panel Introduction

11.5.4 GCC Biotech INDIA Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.5.5 GCC Biotech INDIA Recent Development

11.6 Labmix24

11.6.1 Labmix24 Company Details

11.6.2 Labmix24 Business Overview

11.6.3 Labmix24 Multiplex Sepsis Biomarker Panel Introduction

11.6.4 Labmix24 Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.6.5 Labmix24 Recent Development

11.7 Assay Genie Ltd

11.7.1 Assay Genie Ltd Company Details

11.7.2 Assay Genie Ltd Business Overview

11.7.3 Assay Genie Ltd Multiplex Sepsis Biomarker Panel Introduction

11.7.4 Assay Genie Ltd Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.7.5 Assay Genie Ltd Recent Development

11.8 T2 Biosystems

11.8.1 T2 Biosystems Company Details

11.8.2 T2 Biosystems Business Overview

11.8.3 T2 Biosystems Multiplex Sepsis Biomarker Panel Introduction

11.8.4 T2 Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.8.5 T2 Biosystems Recent Development

11.9 Immunexpress

11.9.1 Immunexpress Company Details

11.9.2 Immunexpress Business Overview

11.9.3 Immunexpress Multiplex Sepsis Biomarker Panel Introduction

11.9.4 Immunexpress Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.9.5 Immunexpress Recent Development

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Multiplex Sepsis Biomarker Panel Introduction

11.10.4 Merck Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)

11.10.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Multiplex Immunoassay

Table 3. Key Players of Microfluidics-Based Panels

Table 4. Key Players of Multiplex Molecular Panels

Table 5. Key Players of Other

Table 6. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Diagnostic Fields (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Sepsis Diagnosis

Table 8. Key Players of Sepsis Prognosis

Table 9. Key Players of Other

Table 10. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Clinical Application Scenarios (US$ Million): 2020 VS 2024 VS 2031

Table 11. Key Players of ED Rapid Triage

Table 12. Key Players of ICU Monitoring

Table 13. Key Players of Antimicrobial Stewardship

Table 14. Key Players of Other

Table 15. Global Multiplex Sepsis Biomarker Panel Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 16. Global Multiplex Sepsis Biomarker Panel Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025) & (US$ Million)

Table 18. Global Multiplex Sepsis Biomarker Panel Market Share by Region (2020-2025)

Table 19. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 20. Global Multiplex Sepsis Biomarker Panel Market Share by Region (2026-2031)

Table 21. Multiplex Sepsis Biomarker Panel Market Trends

Table 22. Multiplex Sepsis Biomarker Panel Market Drivers

Table 23. Multiplex Sepsis Biomarker Panel Market Challenges

Table 24. Multiplex Sepsis Biomarker Panel Market Restraints

Table 25. Global Multiplex Sepsis Biomarker Panel Revenue by Players (2020-2025) & (US$ Million)

Table 26. Global Multiplex Sepsis Biomarker Panel Market Share by Players (2020-2025)

Table 27. Global Top Multiplex Sepsis Biomarker Panel Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Sepsis Biomarker Panel as of 2024)

Table 28. Ranking of Global Top Multiplex Sepsis Biomarker Panel Companies by Revenue (US$ Million) in 2024

Table 29. Global 5 Largest Players Market Share by Multiplex Sepsis Biomarker Panel Revenue (CR5 and HHI) & (2020-2025)

Table 30. Global Key Players of Multiplex Sepsis Biomarker Panel, Headquarters and Area Served

Table 31. Global Key Players of Multiplex Sepsis Biomarker Panel, Product and Application

Table 32. Global Key Players of Multiplex Sepsis Biomarker Panel, Date of Enter into This Industry

Table 33. Mergers & Acquisitions, Expansion Plans

Table 34. Global Multiplex Sepsis Biomarker Panel Market Size by Type (2020-2025) & (US$ Million)

Table 35. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Type (2020-2025)

Table 36. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 37. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Type (2026-2031)

Table 38. Global Multiplex Sepsis Biomarker Panel Market Size by Application (2020-2025) & (US$ Million)

Table 39. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Application (2020-2025)

Table 40. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 41. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Application (2026-2031)

Table 42. North America Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. North America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)

Table 44. North America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)

Table 45. Europe Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)

Table 47. Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)

Table 48. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 49. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025) & (US$ Million)

Table 50. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2026-2031) & (US$ Million)

Table 51. Latin America Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 52. Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)

Table 53. Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)

Table 54. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 55. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)

Table 56. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)

Table 57. Atila Biosystems Company Details

Table 58. Atila Biosystems Business Overview

Table 59. Atila Biosystems Multiplex Sepsis Biomarker Panel Product

Table 60. Atila Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 61. Atila Biosystems Recent Development

Table 62. EDX Medical Company Details

Table 63. EDX Medical Business Overview

Table 64. EDX Medical Multiplex Sepsis Biomarker Panel Product

Table 65. EDX Medical Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 66. EDX Medical Recent Development

Table 67. Seegene Inc Company Details

Table 68. Seegene Inc Business Overview

Table 69. Seegene Inc Multiplex Sepsis Biomarker Panel Product

Table 70. Seegene Inc Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 71. Seegene Inc Recent Development

Table 72. BIOMÉRIEUX Company Details

Table 73. BIOMÉRIEUX Business Overview

Table 74. BIOMÉRIEUX Multiplex Sepsis Biomarker Panel Product

Table 75. BIOMÉRIEUX Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 76. BIOMÉRIEUX Recent Development

Table 77. GCC Biotech INDIA Company Details

Table 78. GCC Biotech INDIA Business Overview

Table 79. GCC Biotech INDIA Multiplex Sepsis Biomarker Panel Product

Table 80. GCC Biotech INDIA Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 81. GCC Biotech INDIA Recent Development

Table 82. Labmix24 Company Details

Table 83. Labmix24 Business Overview

Table 84. Labmix24 Multiplex Sepsis Biomarker Panel Product

Table 85. Labmix24 Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 86. Labmix24 Recent Development

Table 87. Assay Genie Ltd Company Details

Table 88. Assay Genie Ltd Business Overview

Table 89. Assay Genie Ltd Multiplex Sepsis Biomarker Panel Product

Table 90. Assay Genie Ltd Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 91. Assay Genie Ltd Recent Development

Table 92. T2 Biosystems Company Details

Table 93. T2 Biosystems Business Overview

Table 94. T2 Biosystems Multiplex Sepsis Biomarker Panel Product

Table 95. T2 Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 96. T2 Biosystems Recent Development

Table 97. Immunexpress Company Details

Table 98. Immunexpress Business Overview

Table 99. Immunexpress Multiplex Sepsis Biomarker Panel Product

Table 100. Immunexpress Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 101. Immunexpress Recent Development

Table 102. Merck Company Details

Table 103. Merck Business Overview

Table 104. Merck Multiplex Sepsis Biomarker Panel Product

Table 105. Merck Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)

Table 106. Merck Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Multiplex Sepsis Biomarker Panel Picture

Figure 2. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Multiplex Sepsis Biomarker Panel Market Share by Type: 2024 VS 2031

Figure 4. Multiplex Immunoassay Features

Figure 5. Microfluidics-Based Panels Features

Figure 6. Multiplex Molecular Panels Features

Figure 7. Other Features

Figure 8. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Diagnostic Fields (2020-2031) & (US$ Million)

Figure 9. Sepsis Diagnosis Features

Figure 10. Sepsis Prognosis Features

Figure 11. Other Features

Figure 12. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Clinical Application Scenarios (2020-2031) & (US$ Million)

Figure 13. ED Rapid Triage Features

Figure 14. ICU Monitoring Features

Figure 15. Antimicrobial Stewardship Features

Figure 16. Other Features

Figure 17. Global Multiplex Sepsis Biomarker Panel Market Size by Application (2020-2031) & (US$ Million)

Figure 18. Global Multiplex Sepsis Biomarker Panel Market Share by Application: 2024 VS 2031

Figure 19. Hospital Case Studies

Figure 20. Clinic Case Studies

Figure 21. Other Case Studies

Figure 22. Multiplex Sepsis Biomarker Panel Report Years Considered

Figure 23. Global Multiplex Sepsis Biomarker Panel Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 24. Global Multiplex Sepsis Biomarker Panel Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 25. Global Multiplex Sepsis Biomarker Panel Market Share by Region: 2024 VS 2031

Figure 26. Global Multiplex Sepsis Biomarker Panel Market Share by Players in 2024

Figure 27. Global Multiplex Sepsis Biomarker Panel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Multiplex Sepsis Biomarker Panel Revenue in 2024

Figure 29. North America Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. North America Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)

Figure 31. United States Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Canada Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Europe Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)

Figure 35. Germany Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. France Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. U.K. Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Italy Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Russia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Ireland Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Share by Region (2020-2031)

Figure 43. China Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Japan Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. South Korea Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Southeast Asia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. India Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Australia & New Zealand Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Latin America Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)

Figure 51. Mexico Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Brazil Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)

Figure 55. Israel Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. UAE Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Atila Biosystems Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 59. EDX Medical Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 60. Seegene Inc Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 61. BIOMÉRIEUX Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 62. GCC Biotech INDIA Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 63. Labmix24 Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 64. Assay Genie Ltd Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 65. T2 Biosystems Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 66. Immunexpress Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 67. Merck Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions